Skip to content

DePuy Global Unite Shoulder System

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02412397
Enrollment
80
Registered
2015-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2015-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Keywords

Shoulder

Brief summary

To collect medium to long-term survivorship implant outcomes on the DePuy Global Unite Shoulder System

Interventions

PROCEDURETotal Shoulder Arthroplasty

Sponsors

Rothman Institute Orthopaedics
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Patient greater than 18 years of age and skeletally mature * Patient qualifies for primary or revision total or reverse shoulder arthroplasty based on diagnosis of investigator of osteoarthritis, rheumatoid arthritis, post-traumatic arthritis, un-united humeral head fractures, irreducible 3- and 4- part proximal humeral fracture, avascular necrosis, or gross rotator cuff deficiency. * Patient is willing and able to provide written informed consent and to complete scheduled follow up visits/evaluations/questionnaires

Exclusion criteria

* Patient has one of the following compromise the affected limb; a significant injury to the upper brachial plexus, paralysis of the axillary nerve, or a neuromuscular disease compromising the affected limb * Patient has a known or suspected infection * Patient is known to be pregnant * Patient has a sensitivity or allergic reaction to one or more of the implanted materials * Patient is unwilling or unable to provide consent or comply with follow up visits

Design outcomes

Primary

MeasureTime frame
Implant Survivorship10 years post-operative

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026